| The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism (NCT01780168) | National Human Genome Research Institute (NHGRI) | 2012-12-31 |
| Research and Characterization of New Genes Involved in Intellectual Disability (NCT01867554) | Institut National de la Santé Et de la Recherche Médicale, France | 2012-12-31 |
| Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia (NCT01728064) | PTC Therapeutics | 2012-12-31 |
| Improving White Blood Cell Collection From Healthy Donors (NCT01553214) | National Institutes of Health Clinical Center (CC) | 2012-12-31 |
| Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors (NCT01675479) | Abbott Medical Optics | 2012-12-31 |
| A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) (NCT01674361) | Hoffmann-La Roche | 2012-12-31 |
| Thoracic Epidural Versus General Anaesthesia in Cholecystectomy (NCT03107832) | Abant Izzet Baysal University | 2012-12-30 |
| Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain (NCT01760954) | AbbVie | 2012-12-28 |
| Biomagnetic Characterization of Gastric Dysrhythmias III (NCT03176927) | Vanderbilt University Medical Center | 2012-12-28 |
| Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (NCT01732861) | Celgene | 2012-12-28 |
| INHERIT EGFR - Studying Germline EGFR Mutations (NCT01754025) | Dana-Farber Cancer Institute | 2012-12-28 |
| Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer (NCT02459652) | Japan Adjuvant Study Group of Pancreatic Cancer | 2012-12-28 |
| Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy (NCT01755767) | Daiichi Sankyo | 2012-12-27 |
| A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants (NCT01762839) | Melinta Therapeutics, Inc. | 2012-12-27 |
| Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders (NCT01778504) | National Institute of Mental Health (NIMH) | 2012-12-27 |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma (NCT01723020) | Kartos Therapeutics, Inc. | 2012-12-27 |
| Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study (NCT01737671) | M.D. Anderson Cancer Center | 2012-12-27 |
| 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (NCT01843348) | Novartis Pharmaceuticals | 2012-12-27 |
| Efficacy and Safety Study of Ozanimod in Ulcerative Colitis (NCT01647516) | Celgene | 2012-12-26 |
| EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan (NCT01756261) | Bayer | 2012-12-26 |
| Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults (NCT01780506) | Gilead Sciences | 2012-12-26 |
| Ohio Colorectal Cancer Prevention Initiative (NCT01850654) | Ohio State University Comprehensive Cancer Center | 2012-12-26 |
| Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis (NCT01872026) | Astellas Pharma Inc | 2012-12-26 |
| Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis (NCT01659658) | Millennium Pharmaceuticals, Inc. | 2012-12-26 |
| EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan (NCT01756248) | Bayer | 2012-12-26 |
| Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest (NCT03149406) | Centre Hospitalier Universitaire, Amiens | 2012-12-26 |
| A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370) (NCT01636960) | Merck Sharp & Dohme LLC | 2012-12-25 |
| BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer (NCT02783794) | Meabco A/S | 2012-12-24 |
| Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host (NCT02891395) | University Hospital, Lille | 2012-12-24 |
| Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies (NCT01760655) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-24 |
| Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. (NCT01625182) | Novartis Pharmaceuticals | 2012-12-22 |
| Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT) (NCT01674803) | Foundation of Cardiovascular Research and Education Enschede | 2012-12-21 |
| A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003) (NCT01732510) | Merck Sharp & Dohme LLC | 2012-12-21 |
| Omega-3 Fatty Acids and Insulin Sensitivity (NCT01686568) | Mayo Clinic | 2012-12-21 |
| A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) (NCT01721746) | Bristol-Myers Squibb | 2012-12-21 |
| Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome (NCT03197298) | Thorax Centrum Twente | 2012-12-21 |
| The PIONEER-01 Study of the Imagio Breast Imaging System (NCT01943916) | Seno Medical Instruments Inc. | 2012-12-21 |
| Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children (NCT02086214) | University Hospital, Lille | 2012-12-21 |
| Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial (NCT02234830) | Aarhus University Hospital Skejby | 2012-12-21 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma (NCT01730950) | Radiation Therapy Oncology Group | 2012-12-20 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease (NCT01767311) | Eisai Inc. | 2012-12-20 |
| LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer (NCT01685138) | Novartis Pharmaceuticals | 2012-12-20 |
| Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis (NCT01753076) | GlaxoSmithKline | 2012-12-20 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (NCT01724814) | Hanmi Pharmaceutical Company Limited | 2012-12-20 |
| Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis , (NCT01526889) | Novartis Pharmaceuticals | 2012-12-20 |
| Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status (NCT03068559) | Centre Antoine Lacassagne | 2012-12-20 |
| DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial (NCT01745263) | University of Zurich | 2012-12-20 |
| Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) (NCT01698905) | Novartis Pharmaceuticals | 2012-12-20 |
| Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) (NCT01665144) | Novartis Pharmaceuticals | 2012-12-20 |
| Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT01729845) | Fred Hutchinson Cancer Center | 2012-12-20 |
| Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01753713) | Manmeet Ahluwalia, MD | 2012-12-20 |
| IRT and CBT in Sexual Assault Victims With PTSD (NCT03169712) | Laval University | 2012-12-20 |
| Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma (NCT01711528) | National Cancer Institute (NCI) | 2012-12-19 |
| Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method (NCT04841252) | Mayo Clinic | 2012-12-19 |
| Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma (NCT01729338) | Duke University | 2012-12-19 |
| Depth of Anaesthesia and Long-term Survival: The Balanced Anaesthesia Follow-up Study (NCT04965324) | Auckland City Hospital | 2012-12-19 |
| Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism? (NCT02878499) | University Hospital, Strasbourg, France | 2012-12-19 |
| Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia (NCT01736943) | Joseph Tuscano | 2012-12-19 |
| Development of a Novel Human In Vitro Sarcoidosis Model (NCT01857401) | Elliott Crouser MD | 2012-12-19 |
| BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) (NCT01750918) | Novartis Pharmaceuticals | 2012-12-19 |
| CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM (NCT01761643) | University of California, San Diego | 2012-12-19 |
| Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A (NCT01858922) | Baylor College of Medicine | 2012-12-19 |
| AZD1775 for Advanced Solid Tumors (NCT01748825) | National Cancer Institute (NCI) | 2012-12-19 |
| Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis (NCT02594059) | Hopital Foch | 2012-12-19 |
| Comparing the Effectiveness of Combined NRT With Single NRT in Primary Care Clinics in Hong Kong (NCT03836560) | Hospital Authority, Hong Kong | 2012-12-18 |
| Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment. (NCT01750281) | AstraZeneca | 2012-12-18 |
| The Effect of Uric Acid Lowering in Type 1 Diabetes (NCT02344602) | University Health Network, Toronto | 2012-12-18 |
| Effect of Lung Cancer Diagnoses on Family Behaviors (NCT01862770) | National Human Genome Research Institute (NHGRI) | 2012-12-18 |
| 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy (NCT01751451) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer (NCT01596140) | M.D. Anderson Cancer Center | 2012-12-18 |
| Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training (NCT01971528) | Chang Gung University | 2012-12-18 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy (NCT01751776) | Boehringer Ingelheim | 2012-12-18 |
| A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis (NCT01730248) | Novartis Pharmaceuticals | 2012-12-18 |
| A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study (NCT01609933) | AbbVie (prior sponsor, Abbott) | 2012-12-18 |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke (NCT01763606) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| Impact of Physical Therapy Intervention on Foot and Ankle Function (NCT04930406) | Children's Hospitals and Clinics of Minnesota | 2012-12-18 |
| To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers (NCT01751074) | GlaxoSmithKline | 2012-12-17 |
| Peripheral Endothelial Function in COPD Patients (NCT02593357) | Hopital Foch | 2012-12-17 |
| Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma (NCT01645930) | Millennium Pharmaceuticals, Inc. | 2012-12-17 |
| A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects (NCT01691547) | GlaxoSmithKline | 2012-12-17 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) (NCT02085798) | Celgene | 2012-12-17 |
| Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma (NCT01542918) | James Rubenstein | 2012-12-17 |
| Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder (NCT03717493) | Friedrich-Alexander-Universität Erlangen-Nürnberg | 2012-12-17 |
| Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL (NCT01752426) | M.D. Anderson Cancer Center | 2012-12-17 |
| A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients (NCT01725802) | NeuroDerm Ltd. | 2012-12-16 |
| The Effect of Chronic Care Model Based Education on Disease Management in Hypertensive Patients (NCT04411355) | Ege University | 2012-12-15 |
| The Effectiveness of a Post-ICU Recovery Program on Relatives (NCT03264365) | Holbaek Sygehus | 2012-12-15 |
| Drug-coated Balloon in de Novo Chronic Total Occlusions (NCT05977842) | National Institute of Cardiology, Warsaw, Poland | 2012-12-15 |
| Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans (NCT01590277) | VA Office of Research and Development | 2012-12-14 |
| Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction (NCT01491815) | Karolinska Institutet | 2012-12-14 |
| Biomarkers in Post-Menopausal Women Receiving Flaxseed (NCT01698294) | Roswell Park Cancer Institute | 2012-12-14 |
| A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) (NCT01713582) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-12-14 |
| An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE) (NCT01775644) | Hoffmann-La Roche | 2012-12-14 |
| Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer (NCT01619813) | Canadian Cancer Trials Group | 2012-12-14 |
| Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 (NCT01714908) | Jinming Yu | 2012-12-14 |
| Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01757639) | National Cancer Institute (NCI) | 2012-12-14 |
| Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration (NCT01736592) | Sanofi | 2012-12-14 |
| A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients (NCT01753167) | Genentech, Inc. | 2012-12-14 |
| Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse (NCT01959217) | Wayne State University | 2012-12-13 |